Generics 4

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Ponatinib manufacturers

4 products found

Filters

4 products found

ponatinib

Tablets, film coated 15 mg, 30 mg, 45 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
Iceland
GMP approvals
EU GMP
Manufacturer #28915

Manufacturer usually replies in 14 days

ponatinib

Tablets Upon request

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Available for
Licensing with supply
Comments
Only available for Europe
Manufacturer #17385

Manufacturer usually replies in 15 days

ponatinib

Tablets 15 mg, 45 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #16454
A pharmaceutical company based in South America with 15+ years of experience in a drug market. More than 40 products in 25+ countries: LATAM; Wester, Southern and South-eastern Asia. Company’s therapeutic areas consist of products that can used in such areas as: urology, oncology, rare diseases and more.

Manufacturer usually replies in 7 days

ponatinib

Tablets, film coated 15mg, 45mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina, Brazil, Pakistan, Paraguay, Peru, Uruguay, WHO, PICS
Unavailable markets
Argentina , Brazil , Chile , Ecuador , Paraguay , Peru , Uruguay
Manufacturer #16112

Manufacturer usually replies in 6 days

Ponatinib Manufacturer

Ponatinib is available under the brand name “Iclusig”. It belongs to the drug class of Antineoplastic and Tyrosine Kinase Inhibitor”. It is indicated for the treatment of adults with chronic, accelerated, or blast-phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy, or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy. This pharmaceutical medicine can be taken with or without a meal. In case of a missed dose, take the next scheduled dose the following day. Storing at a temperature of 20-25oC (68-77oF); excursions to 15-30oC are permitted. The most common non-hematologic adverse reactions related to this pharmaceutical medicine include hypertension, rash, abdominal pain, dry skin, constipation, arthralgia, and pyrexia. The hematologic adverse reactions include thrombocytopenia, anaemia, neutropenia, lymphopenia, and leukopenia. Your doctor or pharmacist should be informed of your medical history before you take this medicine, especially if you have: liver disease; heart problems (such as angina; high blood pressure); a previous stroke or mini-stroke (transient ischemic attack); diabetes; high cholesterol; and tobacco use. Verify the pregnancy status of females of reproductive potential before beginning the procedure. There is no information on the drug's presence in human milk, its effects on breastfed infants, or its effects on milk production. Women should not breastfeed during treatment and for 6 days after the last dose U.S. Food and Drug Administration has approved Ponatinib for adults with chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).

How does Ponatinib work?

Ponatinib is a kinase inhibitor with multiple targets. There is a constitutively active protein in CML known as Bcr-Abl. It inhibits Abl and T315I mutant kinase tyrosine kinase activity. Due to its ability to block the binding of Bcr-Abl inhibitors, the T315I mutation confers resistance in cells.

The cost of Ponatinib

A 30-tablet supply of Ponatinib oral tablet 10 mg costs approximately $18,711, depending on the pharmacy you visit.

Sourcing the Ponatinib Manufacturer and Suppliers

Navigating our pharmaceutical marketplace

Pipelinepharma is a global online marketplace. It is structured to simplify pharmaceutical deals by providing its customers with an intuitive interface that is easy to engage with. The Ponatinib manufacturers and suppliers list can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. These advanced filters can also filter out the countries for this medicine’s manufacturers and suppliers. These also enable you to check the dossier status of this medicine, and the GMP approvals of the different variants of Ponatinib. Each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Ponatinib is manufactured in

Establishing Commercial ties

Pipelinepharma is a legitimate online pharmaceutical marketplace, which provides a secure and safe B2B platform for drug dealers, wholesalers, and buyers. Sellers with a pharmaceutical license can register and can advertise as many drugs as they want. Moreover, the sellers can interact with the drug distributors and provide tertiary services directly to the buyers.

Quality assurance

Pipelinepharma ensures that only validated manufacturers and wholesalers enter their advertising platform through their pre-auditing and quality control operations, providing a safe B2B pharmaceutical sales platform.